In addition, CD93 serves as a stable prognostic biomarker across most cancer types, with the exception of ACC, BRCA, CHOL, diffuse large B-cell lymphoma (DLBC), PAAD, PRAD, SKCM, and UCS. Here, CD93 is linked to cancer.